Zug
Switzerland
3
2023-10-26
3
2026-05-19
These are the the leading inventors for applications assigned to Pharvaris GmbH:
Pharvaris GmbH based in Zug, CH has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
PROPHYLAXIS AND TREATMENT OF ANGIOEDEMA
#2 | 2022-09-15 ✅ Patent 12,391,681 granted on 2025-08-19(R)-3-(3-CHLORO-5-FLUORO-2-((4-(1H-PYRAZOL-1-YL)-2-METHYLQUINOLIN-8-YLOXY)METHYL)PHENYL)MORPHOLINE DERIVATIVES AND RELATED COMPOUNDS AS BRADYKININ (BK) B2 RECEPTOR ANTAGONIST FOR TREATING SKIN DISEASES
#3 | 2022-05-05 ✅ Patent 12,312,330 granted on 2025-05-271-((S)-1-(3-chloro-5-fluoro-2-((4-(1h-pyrazol-1-yl)-2-methylquinolin-8-yloxy)methyl)phenyl)ethyl)-imidazolidine-2,4-dione derivatives and related compounds as bradykinin (BK) B2 receptor antagonist for treating skin diseases
Also check out PHARVARIS GMBH's (Zug, Switzerland) applicant profile with 8 patent applications submitted.
644217 ⎘